A detailed history of Traynor Capital Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Traynor Capital Management, Inc. holds 5,762 shares of VRTX stock, worth $2.95 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,762
Previous 506 1038.74%
Holding current value
$2.95 Million
Previous $235,000 887.23%
% of portfolio
0.16%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
$396.64 - $516.74 $2.08 Million - $2.72 Million
5,256 Added 1038.74%
5,762 $2.32 Million
Q3 2024

Oct 24, 2024

BUY
$460.0 - $505.78 $232,760 - $255,924
506 New
506 $235,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $131B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Traynor Capital Management, Inc. Portfolio

Follow Traynor Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Traynor Capital Management, Inc. with notifications on news.